Compugen Ltd. CGEN

NAS: CGEN | ISIN: IL0010852080 12/03/2026

2,210 USD (-3,07%)

(-3,07%) 12/03/2026

Grafiek Compugen Ltd.

Grafiek Compugen Ltd.

1 dag1d -3,07%
1 week1w 6,25%
1 maand1m 33,94%
3 maanden3m 47,33%
6 maanden6m 60,14%
1 jaar1j 37,27%
5 jaar5j -76,34%

Compugen Ltd. in het nieuws

Toon enkel gratis nieuws

2 maart 2026 · Compugen Reports Fourth Quarter and Full Year 2025 Results · Persbericht

19 februari 2026 · Compugen to Participate in Upcoming Investor Conferences · Persbericht

17 februari 2026 · Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026 · Persbericht

12 februari 2026 · Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors · Persbericht

17 december 2025 · Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million · Persbericht

10 november 2025 · Compugen Reports Third Quarter 2025 Results · Persbericht

4 november 2025 · Compugen to Participate in Stifel 2025 Healthcare Conference · Persbericht

27 oktober 2025 · Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 · Persbericht

13 oktober 2025 · Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 · Persbericht

6 oktober 2025 · Compugen to Present at SITC 2025 · Persbericht

Profiel Compugen Ltd.

Gezondheidstechnologie

Website: www.cgen.com

Hoofdzetel: Holon Israël

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe